Cerebrospinal fluid and serum biomarkers of cerebral malaria mortality in Ghanaian children

Malaria Journal

Volumn 6, Issue , 2007, Pages

  Armah, Henry B ^a,b   Wilson, Nana O ^a   Sarfo, Bismark Y ^c   Powell, Michael D ^a   Bond, Vincent C ^a   Anderson, Winston ^d   Adjei, Andrew A ^b   Gyasi, Richard K ^b   Tettey, Yao ^b   Wiredu, Edwin K ^b   Tongren, Jon Eric ^e   Udhayakumar, Venkatachalam ^e   Stiles, Jonathan K ^a  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF GHANA   (Ghana)

^c University of Ghana   (Ghana)

^d HOWARD UNIVERSITY   (United States)

^e NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CXCL11 CHEMOKINE; EOTAXIN; FIBROBLAST GROWTH FACTOR; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1 RECEPTOR ACCESSORY PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; INTERLEUKIN 9; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; STROMAL CELL DERIVED FACTOR 1ALPHA; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; BETA CHEMOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FAS LIGAND; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ANEMIA; ARTICLE; AUTOPSY; BONFERRONI ANALYSIS; BRAIN MALARIA; CEREBROSPINAL FLUID; CONTROLLED STUDY; DEATH; DYING; FEMALE; GHANA; HUMAN; HUMAN TISSUE; MALE; MORTALITY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; BLOOD; CHILD; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOASSAY; INFANT; MALARIA; PRESCHOOL CHILD; PROGNOSIS; SURVIVAL RATE;

BIOLOGICAL MARKERS; CHEMOKINE CCL5; CHEMOKINE CXCL10; CHEMOKINES, CC; CHILD; CHILD, PRESCHOOL; E-SELECTIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FAS LIGAND PROTEIN; FEMALE; GHANA; HUMANS; IMMUNOASSAY; INFANT; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-8; MALARIA, CEREBRAL; MALE; PROGNOSIS; SURVIVAL RATE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 38049009931     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-6-147     Document Type: Article

References (55)

1. Low plasma concentrations of interleukin 10 in severe malarial anaemia compared with cerebral and uncomplicated malaria. JA Kurtzhals V Adabayeri BQ Goka BD Akanmori JO Oliver-Commey FK Nkrumah C Behr L Hviid, Lancet 1998 351 9118 1768 1772 10.1016/S0140-6736(97)09439-7 9635949
2. The cerebral-malaria-associated expression of RANTES, CCR3 and CCR5 in post-mortem tissue samples. BY Sarfo S Singh JW Lillard A Quarshie RK Gyasi H Armah AA Adjei P Jolly JK Stiles, Ann Trop Med Parasitol 2004 98 3 297 303 10.1179/000349804225003271 15119976
3. High-level cerebellar expression of cytokines and adhesion molecules in fatal, paediatric, cerebral malaria. H Armah AK Dodoo EK Wiredu JK Stiles AA Adjei RK Gyasi Y Tettey, Ann Trop Med Parasitol 2005 99 7 629 647 10.1179/136485905X51508 16212798
4. Cytokines and adhesion molecules expression in the brain in human cerebral malaria. H Armah EK Wired AK Dodoo AA Adjei Y Tettey R Gyasi, Int J Environ Res Public Health 2005 2 1 123 131 16705810
5. Increased levels of inflammatory mediators in children with severe Plasmodium falciparum malaria with respiratory distress. GA Awandare B Goka P Boeuf JK Tetteh JA Kurtzhals C Behr BD Akanmori, J Infect Dis 2006 194 10 1438 1446 10.1086/508547 17054074
6. Cytokine expression in the brain in human cerebral malaria. H Brown G Turner S Rogerson M Tembo J Mwenechanya M Molyneux T Taylor, J Infect Dis 1999 180 5 1742 1746 10.1086/315078 10515846
7. Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria. NH Hunt GE Grau, Trends Immunol 2003 24 9 491 499 10.1016/S1471- 4906(03)00229-1 12967673
8. A quantitative analysis of the microvascular sequestration of malaria parasites in the human brain. K Silamut NH Phu C Whitty GD Turner K Louwrier NT Mai JA Simpson TT Hien NJ White, Am J Pathol 1999 155 2 395 410 10433933
9. Differentiating the pathologies of cerebral malaria by postmortem parasite counts. TE Taylor WJ Fu RA Carr RO Whitten JS Mueller NG Fosiko S Lewallen NG Liomba ME Molyneux, Nat Med 2004 10 2 143 145 10.1038/nm986 14745442
10. Platelet accumulation in brain microvessels in fatal pediatric cerebral malaria. GE Grau CD Mackenzie RA Carr M Redard G Pizzolato C Allasia C Cataldo TE Taylor ME Molyneux, J Infect Dis 2003 187 3 461 466 10.1086/367960 12552430
11. Pathophysiology of cerebral malaria: role of host cells in the modulation of cytoadhesion. SC Wassmer V Combes GE Grau, Ann N Y Acad Sci 2003 992 30 38 12794044
12. Platelets reorient Plasmodium falciparum-infected erythrocyte cytoadhesion to activated endothelial cells. SC Wassmer C Lepolard B Traore B Pouvelle J Gysin GE Grau, J Infect Dis 2004 189 2 180 189 10.1086/380761 14722881
13. Plasmodium yoelii 17XL infection up-regulates RANTES, CCR1, CCR3 and CCR5 expression, and induces ultrastructural changes in the cerebellum. BY Sarfo HB Armah I Irune AA Adjei CS Olver S Singh JW Lillard Jr. JK Stiles, Malar J 2005 4 63 16359553 10.1186/1475-2875-4-63
14. Differential cellular accumulation of transforming growth factor-beta1, -beta2, and -beta3 in brains of patients who died with cerebral malaria. MH Deininger PG Kremsner R Meyermann HJ Schluesener, J Infect Dis 2000 181 6 2111 2115 10.1086/315493 10837206
15. Angiogenic proteins in brains of patients who died with cerebral malaria. MH Deininger S Winkler PG Kremsner R Meyermann HJ Schluesener, J Neuroimmunol 2003 142 1-2 101 111 10.1016/S0165-5728(03)00250-9 14512169
16. Review Article: blood-brain barrier in falciparum malaria. EN Gitau CR Newton, Trop Med Int Health 2005 10 3 285 292 10.1111/j.1365-3156.2004.01366.x 15730513
17. Evidence of blood-brain barrier dysfunction in human cerebral malaria. H Brown TT Hien N Day NT Mai LV Chuong TT Chau PP Loc NH Phu D Bethell J Farrar K Gatter N White G Turner, Neuropathol Appl Neurobiol 1999 25 4 331 340 10.1046/j.1365-2990.1999.00188.x 10476050
18. Profiles of cytokine production in relation with susceptibility to cerebral malaria. S de Kossodo GE Grau, J Immunol 1993 151 9 4811 4820 8409439
19. Serum levels of the proinflammatory cytokines interleukin-1 beta (IL-1beta), IL-6, IL-8, IL-10, tumor necrosis factor alpha, and IL-12(p70) in Malian children with severe Plasmodium falciparum malaria and matched uncomplicated malaria or healthy controls. KE Lyke R Burges Y Cissoko L Sangare M Dao I Diarra A Kone R Harley CV Plowe OK Doumbo MB Sztein, Infect Immun 2004 72 10 5630 5637 15385460 10.1128/IAI.72.10.5630-5637.2004
20. A low interleukin-10 tumor necrosis factor-alpha ratio is associated with malaria anemia in children residing in a holoendemic malaria region in western Kenya. C Othoro AA Lal B Nahlen D Koech AS Orago V Udhayakumar, J Infect Dis 1999 179 1 279 282 10.1086/314548 9841855
21. Plasma interleukin-10:Tumor necrosis factor (TNF)-alpha ratio is associated with TNF promoter variants and predicts malarial complications. J May B Lell AJ Luty CG Meyer PG Kremsner, J Infect Dis 2000 182 5 1570 1573 10.1086/315857 11023485
22. Cerebral malaria in children: serum and cerebrospinal fluid TNF-alpha and TGF-beta levels and their relationship to clinical outcome. F Esamai J Ernerudh H Janols S Welin C Ekerfelt S Mining P Forsberg, J Trop Pediatr 2003 49 4 216 223 10.1093/tropej/49.4.216 12929882
23. Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites. L Schofield J Villaquiran A Ferreira H Schellekens R Nussenzweig V Nussenzweig, Nature 1987 330 6149 664 666 10.1038/330664a0 3120015
24. Cytokines inhibit the development of liver schizonts of the malaria parasite Plasmodium berghei in vivo. SG Vreden MF van den Broek MC Oettinger JP Verhave JH Meuwissen RW Sauerwein, Eur J Immunol 1992 22 9 2271 2275 10.1002/eji.1830220914 1516619
25. Effects of in vivo administration of anti-IL-10 or anti-IFN-gamma monoclonal antibody on the host defense mechanism against Plasmodium yoelii yoelii infection. F Kobayashi H Ishida T Matsui M Tsuji, J Vet Med Sci 2000 62 6 583 587 10.1292/jvms.62.583 10907683
26. Low Levels of RANTES Are Associated with Mortality in Children with Cerebral Malaria. CC John R Opika-Opoka J Byarugaba R Idro MJ Boivin, J Infect Dis 2006 194 6 837 845 10.1086/506623 16941352
27. Differential regulation of beta-chemokines in children with Plasmodium falciparum malaria. DO Ochiel GA Awandare CC Keller JB Hittner PG Kremsner JB Weinberg DJ Perkins, Infect Immun 2005 73 7 4190 4197 15972509 10.1128/IAI.73.7.4190-4197.2005
28. Serum concentrations of MIP-1 alpha and interleukin-8 in patients suffering from acute Plasmodium falciparum malaria. H Burgmann U Hollenstein C Wenisch F Thalhammer S Looareesuwan W Graninger, Clin Immunol Immunopathol 1995 76 1 Pt 1 32 36 10.1006/clin.1995.1084 7606866
29. Suppression of RANTES in children with Plasmodium falciparum malaria. T Were C Ouma RO Otieno AS Orago JM Ong'echa JM Vulule CC Keller DJ Perkins, Haematologica 2006 91 10 1396 1399 17018392
30. Mig and IP-10: CXC chemokines that target lymphocytes. JM Farber, J Leukoc Biol 1997 61 3 246 257 9060447
31. Immunity to placental malaria. III. Impairment of interleukin(IL)-12, not IL-18, and interferon-inducible protein-10 responses in the placental intervillous blood of human immunodeficiency virus/malaria-coinfected women. S Chaisavaneeyakorn JM Moore J Otieno SC Chaiyaroj DJ Perkins YP Shi BL Nahlen AA Lal V Udhayakumar, J Infect Dis 2002 185 1 127 131 10.1086/338013 11756993
32. Changes in the levels of chemokines and cytokines in the placentas of women with Plasmodium falciparum malaria. AL Suguitan Jr. RG Leke G Fouda A Zhou L Thuita S Metenou J Fogako R Megnekou DW Taylor, J Infect Dis 2003 188 7 1074 1082 10.1086/378500 14513430
33. Cytokine and chemokine responses in a cerebral malaria-susceptible or -resistant strain of mice to Plasmodium berghei ANKA infection: early chemokine expression in the brain. PS Hanum M Hayano S Kojima, Int Immunol 2003 15 5 633 640 10.1093/intimm/dxg065 12697663
34. Cerebral ischemia and angiogenesis. T Hayashi K Deguchi S Nagotani H Zhang Y Sehara A Tsuchiya K Abe, Curr Neurovasc Res 2006 3 2 119 129 10.2174/156720206776875902 16719795
35. Platelets potentiate brain endothelial alterations induced by Plasmodium falciparum. SC Wassmer V Combes FJ Candal I Juhan-Vague GE Grau, Infect Immun 2006 74 1 645 653 16369021 10.1128/IAI.74.1.645-653.2006
36. TGF-beta1 released from activated platelets can induce TNF-stimulated human brain endothelium apoptosis: a new mechanism for microvascular lesion during cerebral malaria. SC Wassmer JB de Souza C Frere FJ Candal I Juhan-Vague GE Grau, J Immunol 2006 176 2 1180 1184 16394007
37. A putative role for platelet-derived growth factor in angiogenesis and neuroprotection after ischemic stroke in humans. J Krupinski R Issa T Bujny M Slevin P Kumar S Kumar J Kaluza, Stroke 1997 28 3 564 573 9056612
38. Increased levels of soluble Fas ligand in serum in Plasmodium falciparum malaria. P Kern M Dietrich C Hemmer N Wellinghausen, Infect Immun 2000 68 5 3061 3063 10769016 10.1128/IAI.68.5.3061-3063.2000
39. Circulating plasma receptors for tumour necrosis factor in Malawian children with severe falciparum malaria. ME Molyneux H Engelmann TE Taylor JJ Wirima D Aderka D Wallach GE Grau, Cytokine 1993 5 6 604 609 10.1016/S1043-4666(05)80011-0 8186373
40. Malaria infection induces rapid elevation of the soluble Fas ligand level in serum and subsequent T lymphocytopenia: possible factors responsible for the differences in susceptibility of two species of Macaca monkeys to Plasmodium coatneyi infection. J Matsumoto S Kawai K Terao M Kirinoki Y Yasutomi M Aikawa H Matsuda, Infect Immun 2000 68 3 1183 1188 10678924 10.1128/IAI.68.3.1183-1188. 2000
41. Cellular changes and apoptosis in the spleens and peripheral blood of mice infected with blood-stage Plasmodium chabaudi chabaudi AS. H Helmby G Jonsson M Troye-Blomberg, Infect Immun 2000 68 3 1485 1490 10678964 10.1128/IAI.68.3.1485-1490.2000
42. Crucial role of tumor necrosis factor (TNF) receptor 2 and membrane-bound TNF in experimental cerebral malaria. R Lucas P Juillard E Decoster M Redard D Burger Y Donati C Giroud C Monso-Hinard T De Kesel WA Buurman MW Moore JM Dayer W Fiers H Bluethmann GE Grau, Eur J Immunol 1997 27 7 1719 1725 10.1002/eji.1830270719 9247583
43. Role of CD40-CVD40L in mouse severe malaria. PF Piguet CD Kan C Vesin A Rochat Y Donati C Barazzone, Am J Pathol 2001 159 2 733 742 11485931
44. Role of the tumor necrosis factor receptor 2 (TNFR2) in cerebral malaria in mice. PF Piguet CD Kan C Vesin, Lab Invest 2002 82 9 1155 1166 12218076
45. Requirement for tumor necrosis factor receptor 2 expression on vascular cells to induce experimental cerebral malaria. B Stoelcker T Hehlgans K Weigl H Bluethmann GE Grau DN Mannel, Infect Immun 2002 70 10 5857 5859 12228317 10.1128/IAI.70.10.5857-5859.2002
46. Fas has a role in cerebral malaria, but not in proliferation or exclusion of the murine parasite in mice. T Ohno F Kobayashi M Nishimura, Immunogenetics 2005 57 3-4 293 296 10.1007/s00251-005-0791-5 15900502
47. A role for Fas-Fas ligand interactions during the late-stage neuropathological processes of experimental cerebral malaria. SM Potter T Chan-Ling E Rosinova HJ Ball AJ Mitchell NH Hunt, Journal of Neuroimmunology 2006 173 1-2 96 10.1016/j.jneuroim.2005.12.004 16414123
48. Pathogenesis, clinical features, and neurological outcome of cerebral malaria. R Idro NE Jenkins CR Newton, Lancet Neurol 2005 4 12 827 840 10.1016/S1474-4422(05)70247-7 16297841
49. Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster. Trans R Soc Trop Med Hyg 2000 94 Suppl 1 S1 90 11103309
50. TNF-alpha-induced chemokine production and apoptosis in human neural precursor cells. WS Sheng S Hu HT Ni TN Rowen JR Lokensgard PK Peterson, J Leukoc Biol 2005 78 6 1233 1241 10.1189/jlb.0405221 16314440
51. Microarray analysis of cytokine and chemokine genes in the brains of macaques with SHIV-encephalitis. Y Sui R Potula D Pinson I Adany Z Li J Day E Buch J Segebrecht F Villinger Z Liu M Huang O Narayan S Buch, J Med Primatol 2003 32 4-5 229 239 10.1034/j.1600-0684.2003.00030.x 14498983
52. Interferon-independent, human immunodeficiency virus type 1 gp120-mediated induction of CXCL10/IP-10 gene expression by astrocytes in vivo and in vitro. VC Asensio J Maier R Milner K Boztug C Kincaid M Moulard C Phillipson K Lindsley T Krucker HS Fox IL Campbell, J Virol 2001 75 15 7067 7077 11435587 10.1128/JVI.75.15.7067-7077.2001
53. Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease. D Galimberti N Schoonenboom P Scheltens C Fenoglio F Bouwman E Venturelli I Guidi MA Blankenstein N Bresolin E Scarpini, Arch Neurol 2006 63 4 538 543 10.1001/archneur.63.4.538 16606766
54. Chemotactic activity on mononuclear cells in the cerebrospinal fluid of patients with viral meningitis is mediated by interferon-gamma inducible protein-10 and monocyte chemotactic protein-1. F Lahrtz L Piali D Nadal HW Pfister KS Spanaus M Baggiolini A Fontana, Eur J Immunol 1997 27 10 2484 2489 10.1002/eji.1830271004 9368600
55. Identification of a T cell chemotactic factor in the cerebrospinal fluid of HIV-1-infected individuals as interferon-gamma inducible protein 10. SA Kolb B Sporer F Lahrtz U Koedel HW Pfister A Fontana, J Neuroimmunol 1999 93 1-2 172 181 10.1016/S0165-5728(98)00223-9 10378881